NM_000179.3(MSH6):c.182C>T (p.Ala61Val) AND Hereditary cancer-predisposing syndrome

Clinical significance:Conflicting interpretations of pathogenicity, Likely benign(1);Uncertain significance(1) (Last evaluated: Oct 9, 2019)

Review status:1 star out of maximum of 4 stars

criteria provided, conflicting interpretations

Based on:
2 submissions [Details]
Record status:
current
Accession:
RCV000776160.2

Allele description [Variation Report for NM_000179.3(MSH6):c.182C>T (p.Ala61Val)]

NM_000179.3(MSH6):c.182C>T (p.Ala61Val)

Gene:
MSH6:mutS homolog 6 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p16.3
Genomic location:
Preferred name:
NM_000179.3(MSH6):c.182C>T (p.Ala61Val)
HGVS:
  • NC_000002.12:g.47783415C>T
  • NG_007111.1:g.5269C>T
  • NM_000179.2:c.182C>T
  • NM_000179.3:c.182C>TMANE SELECT
  • NM_001281492.2:c.182C>T
  • NM_001281493.2:c.-555C>T
  • NP_000170.1:p.Ala61Val
  • NP_000170.1:p.Ala61Val
  • NP_001268421.1:p.Ala61Val
  • LRG_219t1:c.182C>T
  • LRG_219:g.5269C>T
  • LRG_219p1:p.Ala61Val
  • NC_000002.11:g.48010554C>T
Protein change:
A61V
Links:
dbSNP: rs572336612
NCBI 1000 Genomes Browser:
rs572336612
Molecular consequence:
  • NM_001281493.2:c.-555C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000179.2:c.182C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_000179.3:c.182C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281492.2:c.182C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000911215Color Health, Inccriteria provided, single submitter
Likely benign
(Apr 25, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001173917Ambry Geneticscriteria provided, single submitter
Uncertain significance
(Oct 9, 2019)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided1not providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Color Health, Inc, SCV000911215.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Ambry Genetics, SCV001173917.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

The p.A61V variant (also known as c.182C>T), located in coding exon 1 of the MSH6 gene, results from a C to T substitution at nucleotide position 182. The alanine at codon 61 is replaced by valine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown1not providednot provided1not providednot providednot provided

Last Updated: Nov 6, 2021

Support Center